Nearly two decades ago, PTVs in PCSK9 were shown to markedly reduce LDL cholesterol and lower the risk of coronary artery disease, leading directly to the development of targeted PCSK9 inhibitors29. Here, PCSK9 is linked to coronary artery disorder.